Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025:2884:355-368.
doi: 10.1007/978-1-0716-4298-6_21.

Decision Tree for Protein Biomarker Selection for Clinical Applications

Katharina Waury  1
Affiliations

Decision Tree for Protein Biomarker Selection for Clinical Applications

Katharina Waury. Methods Mol Biol. 2025.

Abstract

Discovery of novel protein biomarkers for clinical applications is an active research field across a manifold of diseases. Despite some successes and progress, the biomarker development pipeline still frequently ends in failure. Biomarker candidates that are discovered by appropriate technologies such as unbiased mass spectrometry cannot be validated or translated to immunoassays in many cases. Selection of strong disease biomarker candidates that further constitute suitable targets for antibody binding in immunoassays is thus important to allow routine clinical use. This essential selection step can be supported and rationalized using bioinformatics tools such as protein databases. Here, we present a workflow in the form of decision trees to computationally investigate biomarker candidates and their available affinity reagents in depth. This analysis can identify the most promising biomarker candidates for assay development, while minimal time and effort are required.

Keywords: Antibodies; Bioinformatics; Immunoassays; Online databases; Protein biomarker.

PubMed Disclaimer

References

    1. Califf RM (2018) Biomarker definitions and their applications. Exp Biol Med (Maywood) 243(3):213–221 - DOI - PubMed
    1. Blennow K, Hampel H, Weiner M, Zetterberg H (2010) Cerebrospinal fluid and plasma biomarkers in Alzheimer disease. Nat Rev Neurol 6(3):131–144 - DOI - PubMed
    1. Hernández J, Thompson IM (2004) Prostate-specific antigen: a review of the validation of the most commonly used cancer biomarker. Cancer 101(5):894–904 - DOI - PubMed
    1. Mavrina E, Kimble L, Waury K, Gogishvili D, De San G, José N, Das S et al (2022) Multi-omics interdisciplinary research integration to accelerate dementia biomarker development (MIRIADE). Front Neurol 13:890638 - DOI - PubMed - PMC
    1. Dayon L, Cominetti O, Affolter M (2022) Proteomics of human biological fluids for biomarker discoveries: technical advances and recent applications. Expert Rev Proteomics 19(2):131–151 - DOI - PubMed

LinkOut - more resources